FDA recall D-0279-2023
Sentara Infusion Services · Class II · drug
Product
CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML SYR, antibiotic, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Reason for recall
Lack of sterility assurance
Distribution
Dispensed to Patients Nationwide.
Key facts
- Status
- Terminated
- Initiation date
- 2022-12-27
- Report date
- 2023-02-22
- Termination date
- 2026-02-20
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Chesapeake, VA, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0279-2023